SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-027319
Filing Date
2017-11-22
Accepted
2017-11-22 17:02:31
Documents
1
Period of Report
2017-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3868
  Complete submission text file 0000899243-17-027319.txt   5441
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CAY HOUSE, EP TAYLOR DRIVE LYFORD CAY NEW PROVIDENCE C5 N7776
Business Address CAY HOUSE, EP TAYLOR DRIVE LYFORD CAY NEW PROVIDENCE C5 N7776 407-909-9970
Tuesday Thirteen Inc. (Reporting) CIK: 0001723227 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 171220536